Skip to content


Monday, February 4th 2019. Mr Charles Garvey, CEO of Metabolomic Diagnostics will be attending the Society of Maternal Fetal Medicine (SMFM) next week in Las Vegas.

The SMFM is non-profit, membership organisation based in the US with more than 3,500 physicians, scientists and women’s health professionals around the world. The Society supports the clinical practice of maternal-fetal medicine by providing education, promoting research and engaging in advocacy to optimise the health of high-risk pregnant women and their babies.

The 2019 annual pregnancy meeting will take place at Caesars Palace Hotel, Las Vegas where new ideas and research related to high-risk pregnancies are unveiled and discussed.

Mr Garvey will attend the show from the 13th – 15th February. Contact us to meet our CEO and hear more about our predictor test for pre-term pre-eclampsia, PrePsia™

About Metabolomic Diagnostics

Metabolomic Diagnostics is a biomarker-based diagnostics company based in Little Island, Cork, Ireland and is focused on developing a portfolio of early pregnancy screening test.

The company’s first product, PrePsia™, is focused on Pre-term Preeclampsia screening for first time pregnancies which is an unmet clinical need. This is a serious disease that can cause major disruption during pregnancy leading to the deaths of Mums and Babies and can have serious life-long consequences for the survivors.

Posted in